- Subjects with Hemophilia B already receiving or starting treatment with reformulated
- Subjects who have dated and signed the informed consent form.
- Ongoing treatment of Hemophilia B by a product other than reformulated BeneFIX.
- Participation in the European prospective registry of patients with Hemophilia B
treated with BeneFIX (Wyeth protocol 3090A-101039).